CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 16,835,237 shares (option exercise)
- 4 Option exercise PRESIDENT acquired 15,287,847 shares (option exercise)
- 4 Option exercise Director acquired 87,726,389 shares (option exercise)
- 4 Option exercise Director acquired 269,114,822 shares (option exercise)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K/A Event Exhibits
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 25,000 shares at an average $0.43 ($10,769)
- 4 Open-market buy Director bought 100,000 shares at an average $0.46 ($45,610)
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
Page 25 of 34 · 673 filings